Status:
COMPLETED
Samsung Medical Center-Lymphoma Cohort Study
Lead Sponsor:
Samsung Medical Center
Conditions:
Lymphoma
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
The purpose of this study is to establish a model which can predict the treatment outcome and the risk of treatment-related morbidity in patients with lymphoma.
Detailed Description
Although the cure rate of lymphoma has been increased due to the development of newer effective drugs, a substantial portion of patients is still suffered from relapse. Furthermore, the treatment-rela...
Eligibility Criteria
Inclusion
- Patients who were diagnosed as lymphoma
- Over 15 years old
- Patients who agreed the enrollment of study
- Informed consent for sampling
Exclusion
- Patients who do not want to join the study
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
953 Patients enrolled
Trial Details
Trial ID
NCT00822731
Start Date
September 1 2008
End Date
December 1 2011
Last Update
May 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710